Celexa
There have been serious, life-threatening birth defects linked to Celexa, a selective serotonin reuptake inhibitor (SSRI) prescribed for anxiety and depression, and manufactured by Forest Laboratories, along with Cipramil, Emocal, Sepram, and Seropram.
Along with treating depression, Celexa is often prescribed during pregnancy to help with anxiety. The FDA is strengthening its warning for Celexa due to birth defects including congenital heart defects, Persistent Pulmonary Hypertension of the Newborn (PPHN), abdominal and cranial defects.
Studies have shown that babies born to mothers who took Celexa were more likely to develop PPHN than babies born to mothers who did not take Celexa during pregnancy. PPHN is failure of the normal circulatory transition that occurs after birth.
Other birth defects associated with Celexa, include Arial Septal Defects (‘hole in the heart’ defects), Ventral or Ventricular Septal Defects (hole in the heart wall), valve problems, tricuspid valve (Ebstein’s Anomaly), Mitral Valve, Transposition of the Great Arteries/Vessels, Tetralogy of Fallot, Hypoplastic Left Heart Syndrome (HLHS), Hypoplastic Right Heart Syndrome (HRHS), Tricuspid Atresia, Aortic Stenosis, Pulmonary Atresia, Patent Ductus Arteriosus (PDA), Coarctation of the Aorta, Truncus Arteriosus, Tricuspid Valve Stenosis, Heart Murmur, Pulmonary Stenosis, cranial skull defects, abdominal wall defect, Esophageal Stenosis, Club Foot, Anal Atresia and Spina Bifida.
If you or a loved one suffered using Celexa or an SSRI, contact us.
Join us on
Follow us on 
RSS Feed 